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This thesis is to partly fulfill the requirements of a Master of Science degree. It 
consists of a general literature review followed by a paper for submission to a 
scientific journal. The literature review introduces the topics included in the paper. 
The paper is complete on its own as it has an abstract and introduction, as well as 
materials and methods, results, discussion, and a bibliography. The paper is 
followed by a general summary, general conclusion, and a future research section. 
The paper is written in the style of the Journal of Nutrition. A reference section for 
references cited in the literature review, general summary, general conclusion, and 
future research section concludes this thesis. 
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Literature Review 
Swine Management Practices 
In the past years, farmers and researchers have been searching for the optimal 
balance between pig health and economics. Recently, confinement facilities have 
become increasingly popular. In 2002, just 3% of swine operations in the United 
States housed 53% of the total pigs. Confinement facilities each can house more 
than 5,000 pigs. While small operations of one to 99 pigs make up nearly 57% of 
the total number of operations, they account for only one percent of the total number 
of pigs (1). Confinement practices usually allow producers to grow more piglets to 
market weight on their farms and lead to more economic gains for farmers. Though 
they have been ridiculed for pollution and crowding, confinement facilities also offer 
a method of raising more sows to farrow in less space than do conventional 
methods. 
Farrowing. Confinement facilities have changed the way farmers raise and farrow 
their sows. Currently, the common practice is for a sow to be bred and then spend 
approximately 110 days in a gestation crate. At that time, generally sows are moved 
to farrowing crates for the remaining week of gestation and for the suckling period. 
Farrowing crates allow piglets to suckle the sow but help eliminate the risk of 
crushing. The sow is confined to the center of the crate, but the piglets are allowed 
access to the center as well as the sides of the crate. The sides of the crate usually 
have heating pads so that the piglets will be comfortable in the cooler (65°F) ambient 
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temperature that is optimal for the sows. Usually, sows and piglets stay in farrowing 
crates until weaning time, which is typically 21 days. 
Along with increasing public awareness of animal welfare have come new, or rather 
old, methods of piglet rearing. Because consumers demand a quality product that 
has been produced with as little negative impact on the environment as reasonably 
possible and in an animal-friendly manner, hoop structures (new) and open-pasture 
methods (old) of raising pigs have become increasingly popular. Lawmakers in 
Florida took the issue of animal rights and negative environmental impacts of 
confinement facilities one step further in the fall of 2002 when they made it illegal for 
farmers to house pregnant sows in gestation crates (2). Is this a foreshadowing of 
what is to follow in the rest of the nation? We will have to wait to see. 
Weaning. If allowed to naturally suckle and consume solid-based feed during the 
nursing period, piglets will begin to consume mostly dry feed between the ages of 9 
and 12 weeks of age (3). Swine management practices have decreased the typical 
weaning age down to 3-4 weeks. Some piglets are weaned even earlier, at 1-2 
weeks of age, with the help of segregated weaning pens and added medications in 
the feed (4). At the time of weaning, piglets are separated from their dam and are 
usually grouped with other piglets. The piglets commonly are fed a "starter" or, in 
some cases, a "pre-starter" feed. Both starters and pre-starters usually are pelleted 
and contain high percentages of milk products. They provide a more gradual switch 
from sows' milk to the normal swine feed that consists primarily of ground corn and 
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soybean meal. As the piglets become more accustomed to eating solid foods, they 
are fed grower feeds that are formulated to provide a proper balance of nutrients for 
increased growth rates. Growing pigs to slaughter weight faster is advantageous to 
farmers because a shorter feeding period results in decreased feed costs and space 
for additional pigs, which allows farmers to produce more pigs per year in their 
housing facilities. 
Early weaning alternatives. Recently, some farmers have adopted early-wean 
rearing practices. Early weaning usually refers to weaning piglets between the ages 
of 10 and 14 days (5). Piglets thrive in early weaning practices as long as they are 
kept with their dams long enough to receive the full benefit of colostrum (6). In fact, 
early weaning limits the transfer of disease from the sow herd to animals in the 
nursery. Research shows that aberrant behaviors associated with the stress of early 
weaning, such as tail and sheath sucking, disappear by harvest (5). Early-weaned 
piglets often are fed milk pellets instead of liquid milk replacers before being fed pre- 
starters because of difficulties in feeding liquid feeds to large numbers of piglets. It is 
difficult to keep large amounts of milk replacer wholesome for long periods of time as 
it makes a good environment for microbes to grow. Milk pellets are a good 
alternative because they are composed mostly of milk-based products and contain 
very little plant-derived material. They provide the same nutrients as liquid feeds but 
are more convenient to feed to large numbers of piglets. They can be left in feeders 
so that piglets have ad libitum access to the feed. 
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Although evidence indicates that piglets at 10 d grow faster, have greater feed 
intakes, and have higher gain to feed ratios than do piglets weaned at 21 days (6), 
the practice is not widely used outside of confinement facilities because of the added 
cost of feeding such young piglets the proper diet and medications. Depending on 
the number of piglets a farmer weans and either sells or grows each year, the early 
weaning alternative is not always economically feasible. 
Piglet Nutrition 
Sow milk provides essential antibodies and nutrients to piglets for the duration of the 
suckling period. During the first 48 hours, sows produce colostrum, which is a 
watery, yellowish secretion rich in nutrients and antibodies especially important to 
the survival of the neonate. Colostrum contains high concentrations of 
immunoglobulins that are passed from the dam to the piglets and provides the 
piglets immunity against some pathogens (Table 1) (7). At 0 hours lactation, IgG 
concentration in sow colostrum is 95.6 mg/mL, IgM is 9.1 mg/mL, and IgA is 21.2 
mg/mL. By 48 hours of lactation, the concentrations of these three specific 
immunoglobulins in sow milk decrease to 6.3 mg/mL, 2.7mg/mL, and 5.2 mg/mL, 
respectively, resulting in a decrease in total milk solids and an increase in 
percentage of fat and lactose (7). 
Sow milk composition varies with diet and stage of lactation but on average contains 
about 18% total solids, 6.5% fat, 6% lactose, and 5.5% total protein (Table 2) (7). 
Throughout lactation, milk solids remain relatively constant after cessation of 
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colostrum production. Total fat and lactose increase with duration of lactation, 
whereas total protein decreases at the same time. 
Supplemental milk replacers, Recently, the effects of feeding supplemental milk 
replacers to piglets during the suckling period has been examined; however, the 
benefits of feeding supplemental milk replacer to piglets suckling their dams have 
not been determined. One study notes that litters supplemented with milk replacer 
were heavier at weaning and tended to have more pigs weaned; however, 
performance from weaning to harvest was unchanged (8). Many powdered milk 
formulas are commercially available. These formulas are based on the composition 
of sows' milk to assure that all of the piglets' nutritional requirements are met. Most 
powdered formulas are supplemented with one or two antibiotics, such as 
oxytetracycline or neomycin, to help prevent scours and other common illnesses. 
One problem associated with liquid formula feeding is keeping it wholesome and 
safe for the piglets to consume after it has been reconstituted. Weaning houses for 
early-weaned piglets are usually kept at 83°F. These warm temperatures provide an 
ideal warm and moist environment for bacterial growth in the ad libitum-fed liquid 
formula. Once numbers of pathogenic bacteria in the formula and feeding apparatus 
increase, it is nearly inevitable that the piglets will become ill. For this reason, few 
operations use liquid formulas and those that do must flush the formula delivery 
system after each feeding to remove excess formula and pathogenic microbes that 
might be present. 
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Comparison of Pigs to Humans 
Pigs are a monogastric species. Their entire digestive tract remarkably resembles 
that of humans. Pigs, like humans, have a gastric stomach, small intestine that can 
be separated into the ileum, jejunum, and duodenum, and a large intestine or colon. 
Additionally, pigs and humans are of similar size, which allows for the comparison of 
environmental impacts. These similarities make the pig an ideal model for human 
nutrition studies (9). Neonatal piglets are appropriate models for preterm human 
infants because of their size, nutritional requirements, and vulnerability to the 
environment. Neonatal piglets weigh approximately 900 g when they are born. 
Preterm human infants usually weigh between 500 and 2,500 g. Neonatal humans 
and piglets have decreased ability to absorb dietary fats as compared with that of 
adults. Neonates absorb only 45-80% of the dietary triacylglycerols (TAGs) 
absorbed by adults (10, 11). Both preterm human infants and neonatal piglets have 
difficulty regulating their body temperatures; so, it is sometimes necessary to keep 
preterm infants in incubators, and piglets are routinely kept in warm rooms. 
Preterm Human Infant Nutrition 
Preterm human infants have distinctive nutritional requirements. Because they are 
born before full growth and maturation can occur in utero, preterm infants must be 
supplied with the proper formulation of nutrients postnatally to support growth. The 
ideal growth rate for preterm infants is growth equal to that of a fetus in the womb of 
equal post-conceptual age (12). Reaching this goal is difficult, however, because 
preterm infants are often low-birth weight infants, even for gestational age, and tend 
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to lose weight after birth. In order to balance electrolytes and support growth, 
preterm infant formulas for enteral feeding must supply adequate amounts of water-
soluble vitamins, minerals, and energy, have enough water available for kidney 
function, and supply 67-94 kcal/100 mL (12). 
Though the required dietary lipid concentration is limited only by meeting the 
requirements of the essential fatty acids, linoleic and a-linoleic acids, it is common 
for infant formulas to be comprised of approximately 50 percent of energy from lipid. 
This mixture closely matches the composition of human breast milk in total lipid 
content. Commercial formulas, however, typically have higher concentrations of 
medium-chain triacylglycerols (MCTs) than does human breast milk. Composition of 
human milk is highly dependent on diet composition and does not contain high 
proportions of TAGs rich in medium-chain fatty acids (Table 3, Table 4 (14)) (13). In 
commercial formulas for infants, MCTs account for up to 50 percent of the total lipid. 
It is still unknown whether or not this difference accounts for any digestive or 
absorptive differences in preterm infants fed formula instead of human breast milk. 
When preterm infants were fed human milk, there was no correlation between 
duodenal bile acid concentration and lipid absorption; however, when preterm 
infants were fed a milk replacement formula, there was a significant positive 
correlation between total duodenal bile acid concentration and lipid absorption 
(r=0.630, p<0.001) (15). This finding supports the idea that low total bile acid 
concentration is a limiting factor for the digestion and absorption of MCTs but not of 
long-chain fatty acids in TAGs found in human breast milk. The preceding statement 
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is counterintuitive. Logic would lead one to believe that if the long-chain TAGs 
present in human milk are efficiently hydrolyzed and absorbed in preterm infants, the 
MCTs should be more easily hydrolyzed and absorbed because bile acids and 
lipase are not required for the absorption of all MCTs (16). Because MCTs are 
slightly soluble in aqueous solutions, some are absorbed directly into the mucosal 
cells where they are hydrolyzed intracellularly and the medium-chain fatty acids are 
transported to the liver via the portal vein (16). 
Bile Acids 
Functions. The primary function of bile acids is to emulsify dietary lipids in the 
small intestine to accommodate the absorption of dietary TAGs into the mucosa for 
chylomicron assembly (17). Bile acids also promote the absorption of fat-soluble 
dietary components such as fat-soluble vitamins and drugs. Bile acids interact with 
dietary lipids to form lipid micelles in the lumen of the small intestine. The lipids in 
these micelles are arranged so that their hydrophobic regions are in the center of the 
micelle and their more hydrophilic regions interact with the aqueous contents of the 
small intestine. While the TAGs are in micellar solution, they interact with pancreatic 
lipase, which hydrolyzes the fatty acids from the glycerol backbone. Typically, the 
fatty acids in the 1 and 3 positions are hydrolyzed more readily, resulting in free fatty 
acids and 2-monoacylglycerols for absorption into the mucosa. Once in the 
enterocytes of the small intestine, fatty acids are reassembled into TAGs. These 
TAGs, in conjunction with cholesterol, cholesteryl esters, phospholipids, and 
apolipoproteins, form chylomicrons that subsequently are transferred into lymph and 
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transported to the general circulation. The type of TAG and the size of the 
chylomicrons are dependent on the TAG content of the diet (18). The TAG 
composition of chylomicrons closely matches that of the diet, and the more lipids a 
diet contains, the larger and more numerous the chylomicrons will be in the lymph 
and plasma. 
Cho/estero! metabolism. chylomicrons are lipoproteins that contain about 84% 
TAG, 8% cholesterol, 7% phospholipid, and 2% protein (19). While in the general 
circulation, most of the TAGs in the chylomicron are cleaved by action of lipoprotein 
lipase (LPL), leaving chylomicron remnants, which contain very little TAG, for 
delivery to the liver. Therefore, TAGs carried by the chylomicrons ultimately may 
redistributed to very low-density lipoproteins (VLDLs) in the liver. Once the VLDLs 
are packaged, they are secreted from liver and circulate through the blood. As 
VLDLs circulate, LPL on the surface of capillary cells, primarily in skeletal muscle 
and adipose tissue, stimulates the release of TAGs from the lipoprotein as 
monoacylglycerols and fatty acids that are "shuttled" to the cells, effectively shrinking 
the size of the VLDL. As VLDL deliver their lipid to organs, the ratio of protein to 
lipid is increased and the smaller VLDL are called either intermediate-density 
lipoproteins (I DL) or low-density lipoprotein (LDL), depending on protein:TAG. Low-
density lipoproteins continue to circulate through the body and deliver lipid and 
cholesterol to tissues as needed via LDL receptor-mediated endocytosis. 
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The liver also produces nascent high-density lipoproteins (HDLs). High-density 
lipoproteins contain the lowest lipid to protein ratio of all the lipoproteins. High-
density lipoproteins circulate through the blood and "pick up" cholesterol from 
extrahepatic tissues by action of lecithin:cholesterol acyltransferase activity within 
the HDLs. High-density lipoproteins then return the lipids and cholesterol to the liver 
for recycling. At this point, cholesterol may be used for synthesis of bile acids or 
redistributed throughout the body in lipoproteins by the liver. 
Bile acid synthesis. A high percentage, 50-80%, of cholesterol returning to the 
liver is used for bile acid synthesis (20). The extent of bile acid synthesis has a role 
in plasma cholesterol homeostasis. Production of insufficient amounts of bile acids 
will result in hypercholesterolemia because the cholesterol that returns to the liver 
will be redistributed throughout the body via the blood rather than being secreted as 
cholesterol or bile acids into the gallbladder for storage and eventual excretion to the 
small intestine. The enzyme responsible for regulating the rate of bile acid synthesis 
from cholesterol is cholesterol 7a-hydroxylase (21). Cholesterol undergoes a series 
of hydroxylation, oxidation, and reduction reactions that finally result in the synthesis 
of the primary bile acids. The two principal primary bile acids in humans are cholic 
acid and chenodeoxycholic acid. In pigs, the major primary bile acids are 
chenodeoxycholic acid and hyocholic acid (Figure 1). Hyocholic acid can be found 
in trace amounts in humans, and cholic acid can be found in trace amounts in pigs. 
Primary bile acids are conjugated with either taurine or glycine in the peroxisomes of 
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the liver (22) and then stored in the gallbladder until their release is stimulated by the 
release of cholecystokinin in response to digesta in the duodenum. 
Secondary bile acids. Once in the small intestine, primary bile acids can be 
converted to secondary bile acids by microbes that inhabit the gut. Microbes are 
responsible for additional hydroxylation, and/or reduction steps that result in the 
production of up to five secondary bile acids (Figure 2). Secondary bile acids 
include deoxycholic acid, lithocholic acid, ursocholic acid, ursodeoxycholic acid, and 
hyodeoxycholic acid. Secondary bile acids, as well as unaltered primary bile acids, 
in the small intestine may be reabsorbed and transferred to the liver where they are 
resecreted via bile and stored in the gallbladder in a process called recycling. Those 
bile acids that are not recycled are excreted with the feces. 
Bile acid status. Low interduodenal concentrations of bile acids are a factor in the 
decreased absorption of dietary fatty acids in preterm human infants and in neonatal 
piglets (23, 24). Improving bile acid concentration in the small intestine to the 
minimum micellar concentration has been shown to improve dietary fatty acid 
utilization in neonatal piglets (25, 26, 27, 28). By increasing bile acid concentration 
in the duodenum of preterm human infants or neonatal piglets, their absorption of 
dietary TAGs might be improved. 
Choly/sarcosine. Recently, investigators have introduced an artificially conjugated 
bile acid, cholylsarcosine, which is produced by conjugating cholic acid with 
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sarcosine (29) (Figure 3). Orally administered cholylsarcosine generally is well 
tolerated and does not cause changes in biliary lipid composition or liver function 
(29). Cholylsarcosine increases the digestion and absorption of fatty acids from the 
diet in humans with compromised intestinal function (30, 31), but, unlike glycine and 
taurine conjugates of bile acids, is resistant to bacterial deconjugation and 
dehydroxylation in the intestine (29). These characteristics make cholysarcosine an 
ideal choice as a feed additive for piglets to determine if it increases the absorption 
of dietary lipid. 
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Table 1. 
Concentration of IgG, IgM, and IgA in sow's milk during lactationa
IgG IgM IgA 
Stage of 
Lactation Meanb CIF Mean CV Mean CV 
0 h 95.6 34 9.1 49 21.2 42 
12 h 32.1 51 4.2 58 10.1 60 
24 h 14.2 72 2.7 46 6.3 72 
48 h 6.3 47 2.7 39 5.2 55 
7 d 1.5 41 1.8 44 4.8 45 
14 d 1.0 37 1.5 47 4.8 36 
21 d 0.9 28 1.4 49 5.3 31 
a n = 25 sows. b mg/ml 
~ Coefficient of variance. 
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Table 3 
Estimates of the concentrations of nutrients in mature human milk 






10.5 ± 2.0 
39.0 ± 4.0 
280 ± 26 
aMean ±standard deviation. 
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Abstract 
Preterm infants and neonatal suckling piglets have a limited bile acid pool that may 
hinder absorption of dietary fatty acids, triacylglycerols (TAGs), and other lipid-
soluble nutrients. Because dietary lipids are a valuable source of energy for growth, 
it is important for that TAGs be efficiently absorbed and utilized. The hypothesis of 
this study is that oral administration of 0.2 g/kg body weight daily of cholylsarcosine, 
an artificial bile acid, would decrease fecal excretion of dietary fatty acids and TAGs 
in suckling piglets. Twelve 7-d-old piglets were housed individually in metabolism 
cages and fed a commercial milk replacer with or without oral cholylsarcosine until 
21 d of a e. At 14 d of a e, ' 3C hexadecanoic acid and tri-(D31 hexadecanoic acid) g g 
were administered orally to quantify absorption of dietary fatty acids and TAG. 
22 
Cholylsarcosine treatment decreased fecal excretion of stearic acid (18:0) and 
palmitic acid (16:0) (P <_ 0.02). Cholylsarcosine supplementation had no effect on 
absorption of unsaturated fatty acids of 16 or 18 carbons (P > 0.05). Oral 
supplementation with cholylsarcosine increased fecal excretion of deoxycholic acid 
(P = 0.03). Cholylsarcosine tended to stimulate greater incorporation of palmitic acid 
from dietary TAG into the free fatty acids in blood lipids (P = 0.135). Cholylsarcosine 
did not change incorporation of palmitic acid into plasma TAGs when fed as free 
palmitic acid or as palmitic acid in TAG. Apparent absorption of dietary TAGs was 
increased from 77% in piglets not fed cholylsarcosine to 83% in the piglets that did 
receive oral cholylsarcosine. Together, these results support the hypothesis that 
cholylsarcosine increases absorption of dietary TAGs. 
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Introduction 
Preterm human infants have low lipid absorption during the first few weeks of life (1). 
Several factors contribute to this poor fat absorption including the presence of 
inadequate amounts of lipolytic enzymes, the high percentage of long-chain fatty 
acids in milk, the high percentage of saturated fatty acids, the inadequate 
development of the digestive tract, and the small bile acid pool (1, 2). Long-chain 
fatty acids are hydrolyzed more poorly from milk TAGs for absorption than are short-
or medium-chain fatty acids, and saturated fatty acids are hydrolyzed more poorly 
from milk TAGs for absorption than are unsaturated fatty acids. In addition, a 
relatively small bile acid pool likely limits the absorption of dietary fatty acids in 
preterm human infants (2). 
Neonatal piglets have been used as a model for studies of pediatric growth, nutrition, 
and metabolism for many years (3). Neonatal piglets are similar to human preterm 
infants in their size, organ structure, and nutritional needs (4). Neonatal piglets 
exhibit many of the same limitations of lipid digestion and absorption as do preterm 
human infants. The bile acid pool in very young, suckling pigs is small on a per 
weight basis compared with that in weaned pigs (5). Additionally, lipid absorption in 
neonatal piglets depends on the type of dietary fatty acid and the development of the 
digestive. tract. Like preterm human infants, piglets do not efficiently absorb long-
chain saturated fatty acids (3). Approximately 40% of fatty acids in human milk are 
saturated (6, 7). These saturated fatty acids, palmitic acid and stearic acid in 
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particular, are not effectively emulsified or hydrolyzed from TAGs for absorption by 
piglets. As a result of these similarities, the suckling neonatal piglet is useful as a 
model for the study of lipid absorption in preterm human infants. 
Bile acids, which are essential to the emulsification and absorption of fatty acids and 
other lipid-soluble nutrients from the diet, are synthesized in liver and stored in the 
gallbladder. Cholecystokinin stimulates bile acid release from the gallbladder into 
the small intestine in response to eating. Bile acids act as detergents to emulsify 
lipids. Bile acid concentration in preterm human infants and in neonatal piglets is 
very low compared to that of adults of the same species. This low bile acid 
concentration is likely to cause low dietary lipid absorption because dietary lipids are 
not emulsified, and, therefore, hydrolyzation and absorption of fatty acids from 
dietary TAG can not occur. 
The hypothesis is that oral cholylsarcosine, asynthetically conjugated bile acid, will 
increase the efficiency of dietary fatty acid absorption in neonatal piglets. Improved 
absorption efficiency during the suckling period is expected to result in increased 
energy available for growth of neonatal piglets, thereby increasing rate of gain. To 
test this hypothesis, fecal excretion of fatty and bile acids and incorporation of 
dietary fatty acids and TAG into plasma lipids by suckling piglets with or without 
cholylsarcosine supplementation in their diet was evaluated. Additionally, the 
percentage enrichment by stable isotope labeled dietary TAG and free fatty acid into 
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the plasma lipids of suckling and weaned piglets with or without cholylsarcosine in 
their diet was measured. 
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Materials and Methods 
Experimental Design 
Twelve standard pig metabolism cages were modified to house young piglets. 
Cages were equipped with a removable feeding bottle with a sipper tube attached to 
allow liquid milk replacement formula to be fed and its intake to be measured. 
Stainless steel screens were placed under the flooring of each cage to allow fecal 
collections. The ambient temperature in the room was maintained at 83°F. The 
room was maintained with a cycle of 12 h (7:00 AM -7:00 PM) of light and 12 h (7:00 
PM -7:00 AM) of dark. 
Animal use for this study was approved by the Committee of Animal Care at Iowa 
State University. All regulations were followed. Twenty-four 5-d-old crossbred 
(Duroc x Hampshire x Yorkshire) female piglets were obtained from the Iowa State 
University Swine Research Center. Piglets were obtained in 2 groups of 12. Piglets 
were weighed and placed in metabolism cages in groups of 3 for 2 d to allow for 
adjustment to metabolism cages and for time for piglets to learn how to use the 
feeders. After 2 d, piglets were weighed and placed in individual metabolism cages. 
Piglets were assigned randomly to a treatment: control (formula only) or 
cholylsarcosine (0.2 g/kg body weight cholylsarcosine divided equally and fed twice 
daily with the formula). All piglets were fed ad libitum Piglet Liquwean® milk 
replacement formula (Milk Specialties, Inc., Dundee, IL). The diet contained 25% 
protein, 13% total fat, 43% lactose, 0.15% fiber, and 9.8% ash with the remaining 
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percentage being composed of minerals, extra amino acids, and antibiotics on a dry 
matter basis. The fatty acid composition was 3.2% 14:0, 26.6% 16:0, 3% 16:1, 
13.5% 18:0, 43% 18:1, and 11 % 18:2. Formula was mixed with Ovate r to be 179 g of 
dry powder per liter of formula according to package directions. The formula 
contained two antibiotics, oxytetracycline and neomycin. The inclusion of these 
antibiotics might possibly have an effect on the fatty acid composition of feces, either 
increase or decrease depending on the change in microflora of the small intestine, 
however that effect is probably not significant in the scope of this project. 
Treatments began when the piglets were 7 d old. Piglets were weighed each day at 
the evening feeding. That weight was used to calculate the cholylsarcosine dose for 
the next day for animals in the cholylsarcosine treatment group. Fecal samples from 
morning and evening collections were combined for each piglet and stored at -20°C 
until analysis. When the piglets were 14 d old, 25 mg/kg body weight of each a free 
fatty acid and a TAG were administered orally by gelatin capsule. The free fatty acid 
was 1, 2, 3, 4-13~ hexadecanoic acid, and the TAG was glycerol tri-(D31
hexadecanoic acid). Blood samples were drawn just before administration of the 
labeled lipids and again 4, 8, 12, and 24 h later. An additional blood sample was 
drawn 1 wk later. Blood was collected by using Monoject tubes (Tyco Healthcare 
Group, Mansfield, MA) with 15% EDTA as the anticoagulant. Blood samples were 
stored immediately in ice before centrifugation at 4°C for 20 min at 15,000 x g to 
separate plasma. Plasma was stored in Cryovials (Fisher Scientific, Pittsburgh, PA) 
at -80°C until analysis. When 21 d of age, piglets were weighed, placed in one large 
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pen, and weaned with ad libitum access to pelleted feed. When piglets were 54 d 
old, they were weighed and put back into metabolism cages. Then, the stable 
isotope experiment was repeated by using the procedures already outlined. Fecal 
samples were collected twice per day as previously outlined. Pigs were killed by 
using excess ketamine (Sigma-Aldrich, St. Louis, MO) injection when they were 58 d 
old. 
Chemical Analyses 
Fecal samples were weighed, freeze-dried, and reweighed to determine dry matter 
content. Freeze-dried samples were ground by using a mortar and pestle and then 
stored in desiccators until analyzed for lipid and bile acid composition and for lipid 
class composition. Total lipid content of the feces as well as fatty acid composition 
of the TAG and of free fatty acid fractions of feces and plasma were determined. 
Composition of fatty acids and bile acids in feces were determined by gas 
chromatography according to the method of Batta et al. (8) with a few modifications. 
All standards and samples were treated identically. Fatty acid external standards of 
palmitic, palmitoleic, stearic, oleic, linoleic, linolenic, and arachidonic acids were 
used for peak identification. Bile acid external standards included ursodeoxycholic, 
ursocholic, chenodeoxycholic, hyocholic, lithocholic, and deoxycholic acids. Cholic 
acid and heptadecanoic acid were the internal standards. Equal molar 
concentrations (2.447 µM) of all standards, both internal and external, were used. 
By following the procedure of Batta et al. (8), esterification creates butyl esters of 
fatty acids and bile acids and trimethylsylether derivatives of bile acids. Samples 
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and standards were stored under nitrogen at -20°C until analysis with a gas 
chromatograph (GC). 
Quantification by gas chromatography was performed on a Hewlett Packard 6890 
(Hewlett Packard, now Agilent Technologies, Palo Alto, CA) equipped with a flame 
ionization detector and autosampler by using a Varian Chrompak CP-Sil 5 CB Low 
Bleed/MS fused silica capillary column 25 m x 0.25 mm ID x 0.25 µm film thickness 
(Varian Instruments, Walnut Creek, CA). The carrier gas was helium at a flow rate 
of 1.5 mUmin. The injector temperature was 260°C, and the detector temperature 
was 290°C. The oven temperature gradient was as follows: Initial temperature was 
100°C, which was held for 2 min; then, temperature was increased at a rate of 
35°C/min to a final temperature of 278°C, which was held for 22 min. One microliter 
of each sample was injected onto the column and split 1:10 so the column would not 
be overloaded. 
Lipid extracts of fecal and plasma samples were analyzed for fatty acid composition 
of the TAG and of the free fatty acid fractions as outlined by Li et al. (9). Following 
this procedure, total lipid in plasma or feces are separated into TAG, free fatty acid, 
cholesteryl ester, and phospholipid fractions by solid phase extraction, and 
esterification results in pentafluorobenzyl derivatives of fatty acids in each lipid class. 
Samples obtained were analyzed by gas chromatography:mass spectrometry to 
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determine the percentage enrichment by the stable isotope labeled hexadecanoic 
acid and glycerol tri-hexadecanoic acid in plasma and fecal lipids. 
The mass spectrometer used for analysis of these samples was either a Fisions 
single quadrupole instrument equipped with a Fisions 8035 GC (Thermoquest, San 
Jose, CA) or a Micromass GCT (Waters Corporation, Milford, MA) time of flight 
spectrometer equipped with a Hewlett Packard 6890 GC. The inlet program differed 
for the two instruments because different columns were used in the GCs. For the 
quadrupole spectrometer, the program was as follows: Initial temperature was 150° 
C, which immediately was increased at a rate of 5° C per minute to 275° C and then 
held for 5 minutes. One microliter of sample was injected onto the column with a 
split ratio of 1:25. The column was a Supelco Omegawax fused silica capillary 
column (Sigma-Aldrich Corp., St. Louis, MO). It was 30 m x 0.32 mm ID x 0.25 µm 
film thickness. The carrier gas was helium, and the flow rate was constant at 1.0 mL 
per minute. The total run time for each sample was 30 minutes. 
On the time of flight spectrometer, the column was a J&W DB-5MS (Scientific 
Instrument Services, Inc., Ringoes, NJ), which had these dimensions: 30 m x 0.25 
mm ID x 0.25 µm film thickness. The temperature program for this machine was as 
follows: Initial oven temperature of 120° C was held for one minute. Oven 
temperature was increased at a rate of 10° C per minute to a final temperature of 
280° C, which was held for 23 minutes. The carrier gas was helium, and the flow 
rate was held constant. Fifty microliters of each sample was injected onto the 
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column at a split ratio of 1:50. Both mass spectrometers were run in the negative 
chemical ionization mode and by using methane as the ionization gas. The time of 
flight spectrometer was used because of technical problems with the quadrupole 
instrument. The percentage enrichment values obtained from both machines were 
analyzed together as one data set. 
Statistical Analyses 
To determine differences between treatment groups and ages of piglets, all data on 
the excretion of fatty and bile acids were analyzed by using the Proc Mixed 
procedure in SAS version 8.0 (The SAS Institute, Cary, NC) to accurately analyze 
the repeated measures in this experiment. The LSMeans procedure also was used 
to obtain means and standard errors for fatty and bile acids as well as percentage 
enrichments by stable isotopes. Because two of the piglets in the first group and 
most of the piglets in the second group became ill, n equaled 10 for most analyses. 
When only animals in the cholylsarcosine group were analyzed, n equaled 5. 
Significance was declared when P < 0.05. When P < 0.10, a tendency for groups to 
differ was declared. 
32 
Res u Its 
On average, all piglets consumed approximately 1100 kcal DE/d. This value closely 
matches the NRC prediction of 1010 kcal DE/d (10). Piglets receiving 
cholylsarcosine were expected to have an increased rate of gain when compared 
with those that did not receive cholylsarcosine because cholylsarcosine should 
increase available dietary energy for growth (11). Contrary to predictions, rate of 
gain in piglets fed cholylsarcosine was similar to that of controls (P > 0.05) (Table 1). 
Likewise, there was no significant difference in feed intake. 
Excretion of Dietary Triacylglycerols 
To determine whether bile acid status of piglets limited fatty acid absorption from 
dietary TAG, the effect of supplemental cholylsarcosine on fecal excretion of fatty 
acids was determined. Apparent absorption of dietary TAG in suckling piglets 
supplemented with cholylsarcosine was approximately 83%. In suckling piglets fed 
formula alone (control), apparent absorption was approximately 77%. Fecal output 
did not change between the groups. Cholylsarcosine, however, did influence 
absorption of specific dietary fatty acids. Fecal excretion of palmitic and stearic 
acids was decreased by oral administration of cholylsarcosine (P <_ 0.02) (Table 2). 
Excretion of unsaturated fatty acids of 16 and 18 carbons showed little change as 
expected as they are efficiently hydrolyzed and absorbed in nearly all neonates (12). 
The unsaturated 18 carbon fatty acids were compiled as a group because they co- 
eluted from the column when a program that eluted both fatty acids and bile acids 
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was used. Excretion of all 16 carbon fatty acids and 18:0 decreased as the age of 
the suckling piglets increased (P < 0.05). Excretion of unsaturated 18 carbon fatty 
acids tended to decrease (P = 0.07) as age of the suckling piglets increased. There 
was no interaction between age and treatment effects. 
Excretion of Bile Acids 
To determine the effect of dietary cholylsarcosine on bile acid status, the fecal 
excretion of individual primary and secondary bile acids was determined in piglets 
with and without dietary cholylsarcosine. Total bile acid concentration in the feces of 
piglets fed cholylsarcosine was approximately twice that in feces from piglets fed 
formula only (Table 3). Among the individual bile acids in feces, the concentration of 
deoxycholic acid was increased by dietary cholylsarcosine (P < 0.05). 
Concentrations of the other bile acids in feces were not changed by feeding 
cholylsarcosine (P > 0.05) 
Excretion of all bile acids except deoxycholic acid decreased with increasing age of 
the piglets (Table 3). Only excretion of hyodeoxycholic acid decreased significantly 
as age of the piglets increased (P < 0.01). A trend to decrease excretion of 
chenodeoxycholic acid in feces as age of piglets increased was also present (P = 
0.06). 
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Excretion of chenodeoxycholic acid was numerically higher in piglets fed only 
formula when compared with the excretion of piglets that received cholylsarcosine 
with formula (0.05 vs. 0.014 µmoles/g dry feces respectively). 
Absorption of Dietary Lipids 
To measure the incorporation of the stable isotope-labeled lipids into the fatty acid 
and TAGs of plasma and fecal lipids, percent enrichment by dietary 4-13C 
hexadecanoic acid and glycerol tri-(D31hexadecanoic acid) in plasma and feces was 
calculated (Appendix A). No difference in the enrichment of either TAG or free fatty 
acids of piglet plasma by dietary lipids was evident between the control or 
cholylsarcosine-treated groups (Table 4). Evidently, cholylsarcosine did not 
influence the absorption of hexadecanoic acid when administered as either the free 
acid or the TAG form to an extent great enough to be seen within the limits of this 
experiment. The percentage of enrichment of TAGs in the plasma by the dietary 4- 
13C hexadecanoate is approximately 6 times greater (0.24 vs. 1.46%) in the weaned 
pigs compared with the enrichment in the TAG fraction of suckling piglets regardless 
of cholylsarcosine supplementation (P <_ 0.001) (Table 4), suggesting that weaned 
pigs are much more efficient at absorbing TAGs than are suckling piglets. Fecal 
samples from the weaned pigs were not analyzed for stable isotope content; 
therefore, no data on TAG absorption for pigs weaned at 21 d are available. 
There tends (P = 0.13) to be decreased excretion of dietary TAGs as free fatty acids 
in piglets treated with cholylsarcosine, which indicates that cholylsarcosine 
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stimulates absorption of tri-hexadecanoic acid in suckling piglets (Table 5). No 
differences of excretion of either labeled dietary TAG or labeled free fatty acid in the 
TAG fraction of the feces between cholylsarcosine-treated and control animals were 
observed, indicating that cholylsarcosine does not influence TAG excretion. 
An analysis was performed to determine the time at which the greatest enrichment 
of free fatty acids plus TAG occurs in plasma because of oral administration of 
labeled fatty acid or labeled TAG (Figure 1). Enrichment of plasma free fatty acids 
and TAG four hours after administration of labeled free acid was higher (P < 0.05) 
than enrichment at any other time. That enrichment returns to baseline by 8 h after 
administration of the labeled free acid and does not change for the remainder of the 
experiment. Enrichment of plasma free fatty acids and TAG by orally administered 
labeled tri-hexadecanoic acid shows a slight, nonsignificant increase at 4 h. 
Enrichment of plasma lipids by dietary TAG decreases at 8 h but then increases 
again at 8 and 12 h (P< 0.05). One week later, enrichment is not different from that 
at time 0 h. 
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Discussion 
Excretion of Dietary Triacylglycerols 
cholylsarcosine does increase the apparent absorption of dietary fatty acids in 
neonatal piglets by about 6%; however, this increase did not translate to increased 
gain or gain:feed. The maximum increase in growth that can be expected from a 6% 
increase in lipid absorption is 2.3 g body weight per day given the formula these 
piglets were fed. Considering this fact, it is not surprising that differences in growth 
over the 14 d period were not significant. Fecal excretion of saturated fatty acids 
was decreased significantly by treatment with oral cholylsarcosine (Table 2), which 
is in accordance with other studies that show that when emulsifiers were added to 
the diet or when vegetable oils or short-chain fatty acids were fed to suckling or 
early-weaned piglets, lipid digestibility was improved (13, 14, 15, 16, 17). The 
decrease in fatty acid excretion caused by supplementation with dietary 
cholylsarcosine also agrees with studies that show cholylsarcosine decreases fatty 
acid excretion in humans with compromised bowel function (18, 19). Evidently, the 
supplemented cholylsarcosine enhanced the emulsification of dietary TAGs, thereby 
facilitating the absorption of greater amounts of dietary TAGs. It is possible that, by 
feeding a diet with a higher concentration of saturated fatty acids, greater differences 
in absorption might have been apparent resulting in a change in growth data. 
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Excretion of Bile Acids 
The total bile acid concentration in feces of piglets supplemented with dietary 
cholylsarcosine is almost twice that in feces of piglets fed formula alone. Because 
cholylsarcosine is not deconjugated or dehydroxylated in the lumen of the small 
intestine (20), it must have been recycled via enterohepatic circulation like it is in 
humans (20) as it was not detected in the feces of piglets treated with 
cholylsarcosine during the current experiment. 
cholylsarcosine increased the concentration of deoxycholic acid in the feces of 
suckling piglets. A likely cause of this effect is that when cholylsarcosine is recycled, 
sarcosine is replaced by either taurine or glycine. Once reconjugated, the molecule 
that exists is tauro- or glycocholic acid. Either of these bile acids can be modified in 
the small intestine by microbes to produce deoxycholic acid and other secondary 
bile acids (21). An increase in deoxycholic acid because of cholylsarcosine 
supplementation is reasonable, noting that cholic acid is its primary bile acid 
precursor and supplemental cholylsarcosine, increased cholic acid in the intestines. 
Excretion of chenodeoxycholic acid is numerically lower in piglets treated with 
cholylsarcosine than in control piglets (Table 3). In humans, primary bile acids, as 
well as cholylsarcosine, are inhibitors of cholesterol 7a-hydroxylase, which is the 
enzyme responsible for committing cholesterol to bile acid synthesis (22). The same 
inhibitory action is probably present in neonatal piglets because chenodeoxycholic 
acid, a primary bile acid, is decreased by cholylsarcosine supplementation. 
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The average daily change in bile acid excretion with increasing age of piglets was 
and small for all bile acids and negative for all bile acids except deoxycholic acid 
(Table 3) indicating that the bile acid recycling pathway becomes more efficient with 
increasing age. If piglets produce the same amount of bile acids each day but are 
more efficient at recycling them, a decrease in fecal output of bile acids would be 
expected. 
Absorption of Dietary Lipids 
Enrichment of plasma hexadecanoic acid and tri-hexadecanoic acid by labeled free 
acid as well as TAG was increased in weaned pigs when compared with the 
enrichment in suckling piglets regardless of treatment (Table 4), indicating that older 
weaned pigs more efficiently hydrolyze and absorb dietary lipids than do suckling 
piglets. This finding agrees with previous findings (15, 23, 24, 25) that suckling 
piglets have lesser ability to utilize dietary lipids than do weaned pigs. 
Enrichment of fecal hexadecanoic acid and tri-hexadecanoic acid by labeled free 
acid as well as TAG was not different between piglets treated with cholylsarcosine 
and those that received formula alone (Table 5). However, cholylsarcosine tended 
to decrease the enrichment by labeled TAG in the free fatty acid fraction of the feces 
of suckling piglets (P = 0.135). This increase in free fatty acids from dietary TAGs in 
the feces of control animals suggests that cholylsarcosine might increase the rate of 
emulsification, hydrolysis, and subsequent absorption and thus allow utilization of 
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dietary lipids before the digesta moves to the colon and is excreted. These findings 
support those of Verkade et al. (26) in which it was found that most of the dietary 
lipids detected in the feces of preterm infants were in the free fatty acids. 
The enrichment pattern of plasma of suckling piglets after oral administration of 
labeled free hexadecanoic acid and tri-hexadecanoic acid in the shown in Figure 1 
shows the dynamics of lipid homeostasis. At time 4 h, enrichment by orally 
administered free hexadecanoic acid was increased in both the free fatty acids and 
TAGs of plasma, indicating that neonatal piglets are capable of absorbing free fatty 
acids and esterifying them into plasma TAGs. Orally administered TAG does not 
appear in either plasma free fatty acids or TAGs in quantities as high as those of oral 
free acid at 4 h, indicating that piglets do not absorb dietary TAGs as quickly as they 
absorb dietary free acids. By 8 h, all enrichment values of both plasma lipid 
fractions by both dietary lipids have returned to baseline. However, at 12 h, the 
enrichment of plasma free fatty acids by dietary labeled TAG begins to increase. By 
24 hours this increase in enrichment reaches significance (P < 0.05). This increase 
in enrichment by dietary TAG 24 h after administration is probably meal related. 
When animals are fed, they generally store energy in adipose tissue for use by the 
body when food is not available. When an animal fasts between meals, fatty acids 
and glycerol are hydrolyzed from stored TAGs for use as energy (27). Piglets are 
diurnal in that they generally eat and are active during the light hours. Because the 
lights were turned off at 12 hours, piglets probably did not eat. During this fast, 
piglets mobilized TAG stores from adipose tissue that had been stored earlier in the 
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day, TAG stores that were labeled with stable isotopes. The result is an increase in 
the enrichment of plasma lipids by stable isotope-labeled TAGs that were mobilized 
from adipose stores. One week later, the labeled TAG and free fatty acids in the 
plasma have been oxidized and cleared from the body as carbon dioxide and the 
enrichment was decreased and is back to baseline. The same effect is not seen in 
the orally administered free fatty acids probably because they were oxidized and 
cleared from the body much earlier. 
Conclusion 
Bile acids probably are one of the limiting factors in lipid absorption in neonatal 
piglets. Results from this study indicate that the addition of an orally administered 
bile acid improves saturated fatty acid absorption. No change in growth, however, 
was observed. A longer-term study or more piglets seems necessary to determine if 
cholylsarcosine increases the growth rate of neonatal piglets. If a longer-term study 
using piglets as a model for preterm infants does show an increase in growth 
because of supplementation with cholylsarcosine, it may be feasible to supplement 
preterm human infants with cholylsarcosine to improve absorption of dietary TAGs 
and lipid-soluble nutrients. At least, the findings might support a clinical trial with 
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Table 1. 
Daily formula intake and growth of suckling piglets from 7 to 21 days of age 
Cholylsarcosine Control P-value 
Total Gain (kg)b 4.31 4.21 NSa
Average Daily Gain (g/d)b 308 301 NS 
Intake (Ud) 1.41 1.42 NS 
Feed Efficiency° 1.22 1.18 NS 
a Not significant. 
b G rowth over 14 d. 

















































O O O O O 
Q O ~ O O 
O 
O ~- N  ~ M 
I~ O 00 ~ 













CO 07 ~ ~ 
~ ~ ~ o0 . . 
nj O O O 
T 
~ d' O N 
O CV t- ~ 




00 ~ C~ N 








O r O 
C~ 00 00 
~ ~ ~ ~ 
~ ~ ~ 00 ,.~ ~ ~ .. 
~ ~ ~ 
~ ~ ~ ~ 
~~ — ~ 
~ ~ ~ . ~ > a~ .~   
_~ ~ ~ • • ~_ 
~ O .~ .O-~ ~ ~ ~--~ ~ ~ N O 
per}' X ~ ~ c~ ~ ~~ ~ 
to ~ ~~ 
.0 
~ 
(~ O ~ ~ ~ -~.-~ ~_ _~, ctS 






Q. j, cn O 
~ ~ ~ U ~ ~ ~ o 
O N ~ ~ U 
~ ~ ~ `+U- ~ :{~ ~,}~ 
~~ ~~ c~ 
~ U ~ ~ ~ ~ ,>' O ~ Q 
~ ~ U V N 
~ ~ O ~ ~ 
+I O ,~ Q 
~ ~ O O ~ c~ ~ ♦--~ 
N N ~ ~ QO 
~ Q U > O II 





























~ o c~ r~ a~ o oN co 00 O ~- CO ~ ~ O  O O 
Q 0 0 0 0 0 ~ 0 O 
N 
~ CO ~t C~ O I~ O d' O 









M  (~ CV ~t C7 ~ M M 
_O O _O _O _O _O _OO 
`- >C X  X X X X X X 
S  O N d' N L,(') r T 
f~ ~j r 00 ~ 00 ~ 
































































































U 'O  ~ 
Q ~ U U 
~+ Q
~ O U 
~ ~' ~ 











U ~ O 
X N 
a°~ o 




~ ~ ~ `'— O 
U~ 
~, U 
~ ~ ~ 
~ ~ ._ 
~ ~ ~ 
O ~ ~ 
~ ~ 
.O 




~ ~ ~ 
~-
~ U O 
U ~ ~ ~ 
Q ~ ~ ~ ~ X ~ c~ 




~ ~ ~ ~ U 
~ ~ ~ ~ .~ 
~ U > ~ ~ .0  ~ ~ i  ~ 
~ ~ Q ~ .~ . . }, 
~ ~ O ~ ~ ~ ~ :~_. ~ 
~ ~--
N ~~ U ~ 
O  ~ .~ W 
~~ .~/ 
~ ~ ~ U ~ 
C~ ~ .~ (~ Q
~ ~ ~ ~_ 
~ U Q ~ ~ 
~ (~ ~ .~ 'i 
i  U ~ ~ 
Q ~ ~ ~ ~ 
~ ~ ~ ~ ~ ~ ~ ~ ~ 
oa~~~ 
~ ~ ~ ~ ~ 
~ (CS U '~ In 
~_ ~ 
U 
~ ~ ~ 
U ~ ~ ~ .~ 
~ ~ ~ U V ~ 
~-• ~ ~ (n ~ • -
+I ~ ~ ~~ ~ ~ ~ v  `~~~~~Qo 
~~ax>o ii 
45 
~~ c~ ~ 
~ ~U ~ ~ 
~ U 
U '—~ O 
~ ~ ,}- c~ 





















~ ~, (~ 
~ ~ ~ 
~ U ~ 
~ ~ X 
~ ;~ N 

































































































—~ U ~ 
~+ ~ U T ' 
cCS ~ +~ ., ~ 







O .~ ~ 
























~ ~ U 
N 
~ O 




~ ~ c~ 
U ~ ~ 
~ ~ N 
~ ~ ~ 
+~ O 'u~ 
~ ~_ O 
U ~~ i 
O U ~ Q  ~  
t~ _~+ 
~ ~ O 
_~~ 
cn ~ O U ~ ~ 
'~ can U ~ 
_ ~ o 
~~ ~ 
~ ~ O O ~ 
~ .O O 
~ ~ 
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Figure 1. Transfer of dietary hexadecanoic acid or glycerol tri-
hexadecanoic acid to free fatty acids and triacylglycerols in plasma in 
suckling piglets. 
* indicates difference (P < 0.05) within dietary lipid and plasma lipid. 
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Preterm human infants and neonatal piglets have decreased ability to utilize dietary 
lipids compared with that of adults of the same specie. Malabsorption of dietary 
lipids leads to inefficient use of calories and nutrients available in the formula. 
Increasing the absorption of dietary lipids would increase the energy available for 
growth of the neonatal piglet or preterm human infant. 
Cholylsarcosine was tested as an agent that might increase the absorption of dietary 
lipids, mainly TAGs, by improving the emulsification process in the small intestine. 
Cholylsarcosine was supplemented orally to 7 to 21-d-old piglets at a rate of 0.2 
g/d•kg of body wt. Piglets were used as a model for preterm infants. Intake and 
fecal output were measured. Fatty acid and bile acid concentrations in the feces 
were determined by analysis by gas chromatography. Astable isotope-labeled TAG 
and free fatty acid were administered when piglets were 14- and 55-d-old to 
compare incorporation of dietary lipids into plasma lipids in piglets treated with 
cholylsarcosine and those that received formula alone and in weaned piglets. 
Incorporation of stable isotopes was measured by using GC:MS. 
Results show a decrease in saturated fatty acid and some change in bile acid 
excretion in response to treatment with cholylsarcosine. Excretion of all fatty acids 
and most bile acids decreased with increasing age of the piglets, indicating that, as 
piglets become older, the mechanism for fatty acid absorption and for bile acid 
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recycling become more efficient. Enrichment of plasma lipids by stable isotope 
labeled dietary lipids was greater in weaned pigs than in either group of piglets, 




Bile acids probably are one of the limiting factors in lipid absorption in neonatal 
piglets. Results from this study indicate that the addition of an orally administered 
bile acid improves saturated fatty acid absorption. No change in growth, however, 
was observed. A longer-term study or more piglets seems necessary to determine if 
cholylsarcosine increases the growth rate of neonatal piglets. If a longer-term study 
using piglets as a model for preterm infants does show an increase in growth 
because of supplementation with cholylsarcosine, it may be feasible to supplement 
preterm human infants with cholylsarcosine to improve absorption of dietary TAGs 
and lipid-soluble nutrients. At least, the findings might support a clinical trial with 




One interesting thought is the possibility that researchers are overlooking the optimal 
formula for feeding preterm human infants. Human breast milk is accepted widely 
as the optimal food for term infants (14), but is it the best food for preterm human 
infants? The composition of some other mammalian milks might give insight to the 
optimal food in this particular case. Rabbits, opossums, and kangaroos, for 
instance, are born as virtual fetuses, which is similar to a preterm human infant. The 
milk of these animal species tends to be richer in short- and medium-chain TAGs as 
opposed to the long-chain TAGs that make up the majority of lipid in human and 
other more precocious mammalian milks (Table 1 (32)). Up to 50% of the calories in 
infant formulas currently on the market come from medium-chain fatty acids, but 
commercial formulas have no short-chain TAGs (33). Octanoate (8:0), the shortest-
chain fatty acid that is present in commercial formulas is very well absorbed (100%) 
by infants; however, it accounts for only 0.5 to 12 % of the total fatty acids (33). 
Moya et al. (33) also found that, when 16:0 was present in the sn-2 position of the 
dietary TAG, it was much more efficiently utilized than the 16:0 in the sn-1 or sn-3 
positions. Mathews et al. (34) tested the effect of source of long-chain fatty acid on 
the plasma docosahexanoic acid concentrations in neonatal piglets and found that 
algal or fungal sources of TAG were absorbed more efficiently than were the same 
long-chain fatty acids from egg phospholipid. According to the findings of Matthews 
et al. (34), use of egg phospholipids as the source of long-chain fatty acids in 
preterm human infant formulas should be minimized because they are not as 
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absorbable as algal or fungal sources. By using algal or fungal sources of TAGs, 
digestion and absorption of nutrients would be improved. 
Maybe the ideal preterm infant formula would be one that combines the best of 
human breast milk with the advantages of the short- and medium-chain TAGs 
present in some other mammalian milk. Medium-chain TAGs currently are used in 
commercial formulas; however, short-chain TAGs are never included. By including 
more medium- and short-chain fatty acids and components of human breast milk 
such as linoleic acid, protein, and lactose, the resulting formula might be a more 
perfect food for preterm human infants. In the future, it would be interesting to 
formulate a preterm human infant formula that would take into consideration the 
absorption of different lipids and contain short- and medium-chain fatty acids as well 
as the essential long-chain fatty acids from the most absorbable sources. That 
formula then should be fed to very young neonatal piglets as a model for preterm 
human infants to determine their ability to utilize the TAGs present in the new 
formula. One would hypothesize that the short- and medium-chain TAGs would be 
almost completely absorbed and utilized, which would allow the neonate to take full 
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Molecular ion of hexadecanoic acid: 255 
Molecular ion of hexadecanoic acid enriched with two 13C atoms: 257 
Natural abundance of molecular ion 257: 1.98% 
Molecular ion of 13C4 hexadecanoic acid: 259 
Molecular ion of D31 hexadecanoic acid: 286 
In samples, hexadecanoic acid (255) overloaded the column when enough sample 
was injected to elute stable isotope peaks, so, the hexadecanoic (257) peak was 
measured. The area of the 255 peak was obtained by calculation from natural 
abundance. 
1.98 _ Area of 257 
100 Area of 255 
To calculate percentage enrichment of 259: 
Area 259 
`Area 255 +Area 25~ 
To calculate percentage enrichment of 286: 
x 100 
Area 286 ~  x 100 
Area 255 +Area 286 
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